Biotech

All Articles

Neurocrine's KarXT competitor attacks in stage 2-- however merely at reduced dose

.Neurocrine Biosciences has accomplished its own hoped-for account in a stage 2 mental illness test,...

Vaderis' unusual capillary ailment drug minimizes nosebleeds

.Vaderis Therapeutics' objective to develop the first medicine targeted specifically at a particular...

Navigator brings up $100M to create brand-new autoimmune pipe

.Navigator Medicines has actually furnished on its own along with $one hundred thousand in series A ...

Duality looks for cash for ADC trials as IPO surge spreads to Asia

.China's Duality Biotherapeutics has actually filed (PDF) documentation for a Hong Kong IPO, seeking...

YolTech sells China legal rights to gene editing treatment for $29M

.4 months after Mandarin gene modifying company YolTech Therapeutics took its own cholesterol levels...

Addex sell rises after Indivior provides to $300M for compound

.Indivior is getting a tiny particle allosteric modulator designed to alleviate substance usage diso...

Molecular Allies tweaks AML trial over 'suboptimal direct exposure'

.Molecular Partners has actually identified "suboptimal direct exposure" to its tetra-specific T-cel...